Cargando…
Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period
PURPOSE: Hereditary cancer genetic testing can inform personalized medical management for individuals at increased cancer risk. However, many variants in cancer predisposition genes are individually rare, and traditional tools may be insufficient to evaluate pathogenicity. This analysis presents dat...
Autores principales: | Esterling, Lisa, Wijayatunge, Ranjula, Brown, Krystal, Morris, Brian, Hughes, Elisha, Pruss, Dmitry, Manley, Susan, Bowles, Karla R., Ross, Theodora S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469614/ https://www.ncbi.nlm.nih.gov/pubmed/32923914 http://dx.doi.org/10.1200/PO.20.00020 |
Ejemplares similares
-
Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis
por: Holmstrom, Sam R., et al.
Publicado: (2019) -
BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm
por: Lopez-Perez, Gerardo, et al.
Publicado: (2022) -
Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm
por: Morris, Brian, et al.
Publicado: (2016) -
Promises and perils of the FDA's over-the-counter naloxone reclassification
por: Zhu, David T., et al.
Publicado: (2023) -
Reclassification of genetic variants in children with long QT syndrome
por: Westphal, Dominik S., et al.
Publicado: (2020)